Skip to main content
Erschienen in: Intensive Care Medicine 5/2008

01.05.2008 | Original

Intensive care unit acquired infection and organ failure

verfasst von: Pierre Damas, Didier Ledoux, Monique Nys, Mehran Monchi, Patricia Wiesen, Benoît Beauve, Jean-Charles Preiser

Erschienen in: Intensive Care Medicine | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

To assess the temporal relationship between ICU-acquired infection (IAI) and the prevalence and severity of organ dysfunction or failure (OD/F).

Design and setting

Observational, single center study in a mixed intensive care unit of a university hospital.

Patients

We analyzed 1,191 patients hospitalized for more than 2 days during a 2-year observation period: 845 did not acquire IAI, 306 of whom had infection on admission (IOA); 346 did acquire IAI, 125 of whom had IOA.

Measurements and results

The SOFA score was calculated daily, both SOFAmax, the sum of the worst OD/F during the ICU stay, and SOFApreinf, the sum of the worst OD/F existing before the occurrence of the first IAI. The SAPS II and SOFA score of the first 24 h were significantly higher in patients with than in those without IAI. SOFApreinf of IAI patients was also higher than the SOFAmax of patients without IAI both in patients with (12.1 ± 4.6 vs. 8.9 ± 4.7) and those without IOA (9.2 ± 4.0 vs. 6.7 ± 3.5). SOFApreinf represented 85.7% of the value of SOFAmax in patients with IAI. SOFApreinf increased significantly with the occurrence of sepsis, severe sepsis, or septic shock during ICU stay. Severe sepsis and septic shock during ICU stay as well as SOFApreinf were part of the factors associated with hospital mortality.

Conclusions

IAI is significantly associated with hospital mortality; however, its contribution to OD/F is minor. Moreover, severity of IAI seems to be related to previous health status.
Literatur
1.
Zurück zum Zitat Pittet D, Herwaldt L, Massanari R (1992) The intensive care unit. In: Bennett JV, Brachman PS (ed) Hospital infection, 3rd edn. Little Brown, Boston, pp 405–439 Pittet D, Herwaldt L, Massanari R (1992) The intensive care unit. In: Bennett JV, Brachman PS (ed) Hospital infection, 3rd edn. Little Brown, Boston, pp 405–439
2.
Zurück zum Zitat Smith RL (2006) Prevention of infection in the intensive care unit. Curr Opin Infect Dis 19:323–326PubMedCrossRef Smith RL (2006) Prevention of infection in the intensive care unit. Curr Opin Infect Dis 19:323–326PubMedCrossRef
3.
Zurück zum Zitat Bearman GM, Munro C, Sessler CN, Wenzel RP (2006) Infection control and the prevention of nosocomial infections in the intensive care unit. Semin Respir Crit Care Med 27:310–324PubMedCrossRef Bearman GM, Munro C, Sessler CN, Wenzel RP (2006) Infection control and the prevention of nosocomial infections in the intensive care unit. Semin Respir Crit Care Med 27:310–324PubMedCrossRef
4.
Zurück zum Zitat American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
5.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Sutter PM, Thijs LG (1996) The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710PubMedCrossRef Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Sutter PM, Thijs LG (1996) The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710PubMedCrossRef
6.
Zurück zum Zitat Vincent JL, De Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 26:1793–1800PubMed Vincent JL, De Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 26:1793–1800PubMed
7.
Zurück zum Zitat Brun-Buisson C, Meshaka P, Pinton P, Vallet B; The EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30:580–588PubMedCrossRef Brun-Buisson C, Meshaka P, Pinton P, Vallet B; The EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30:580–588PubMedCrossRef
8.
Zurück zum Zitat Vincent JL, Sakr Y, Sprung CH, Ranieri M, Reinhart K, Gerlach H, Moreno R, Carlet J, Legall JR, Payen D (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef Vincent JL, Sakr Y, Sprung CH, Ranieri M, Reinhart K, Gerlach H, Moreno R, Carlet J, Legall JR, Payen D (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef
9.
Zurück zum Zitat Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef
10.
Zurück zum Zitat Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United states from 1979 through 2000. N Engl J Med 348:1546–1554PubMedCrossRef Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United states from 1979 through 2000. N Engl J Med 348:1546–1554PubMedCrossRef
11.
Zurück zum Zitat Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Intensive Care Med 25:686–696PubMedCrossRef Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Intensive Care Med 25:686–696PubMedCrossRef
12.
Zurück zum Zitat McCabe WR, Jackson GG (1962) Gram-negative bacteraemia, aetiology and ecology. Arch Intern Med 110:845–853 McCabe WR, Jackson GG (1962) Gram-negative bacteraemia, aetiology and ecology. Arch Intern Med 110:845–853
13.
Zurück zum Zitat Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84PubMedCrossRef Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84PubMedCrossRef
14.
Zurück zum Zitat Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123PubMedCrossRef Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123PubMedCrossRef
15.
Zurück zum Zitat Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMedCrossRef Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMedCrossRef
16.
Zurück zum Zitat Gerard C (2003) Complement C5a in the sepsis syndrome—too much of a good thing? N Engl J Med 348:167–169PubMedCrossRef Gerard C (2003) Complement C5a in the sepsis syndrome—too much of a good thing? N Engl J Med 348:167–169PubMedCrossRef
17.
Zurück zum Zitat Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488–493PubMed Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488–493PubMed
18.
Zurück zum Zitat Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jachinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606–618PubMedCrossRef Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jachinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606–618PubMedCrossRef
19.
Zurück zum Zitat Kooi T van der, de Boer A, Manniën J, Wille J, Beaumont M, Mooi B, van den Hof S (2007) Incidence and risk factors of device-associated infection and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med DOI 10.1007/s00134-006-0464-3 Kooi T van der, de Boer A, Manniën J, Wille J, Beaumont M, Mooi B, van den Hof S (2007) Incidence and risk factors of device-associated infection and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med DOI 10.​1007/​s00134-006-0464-3
Metadaten
Titel
Intensive care unit acquired infection and organ failure
verfasst von
Pierre Damas
Didier Ledoux
Monique Nys
Mehran Monchi
Patricia Wiesen
Benoît Beauve
Jean-Charles Preiser
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 5/2008
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1018-7

Weitere Artikel der Ausgabe 5/2008

Intensive Care Medicine 5/2008 Zur Ausgabe

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.